Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle.
about
Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humansRole of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models.SOCS2 negatively regulates growth hormone action in vitro and in vivoHormone replacement therapy and physical function in healthy older men. Time to talk hormones?Fasting levels of growth hormone are associated with carotid intima media thickness but are not affected by fluvastatin treatmentSafety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial.Consensus and discordance in the management of growth hormone-treated patients: results of a knowledge, attitudes, beliefs, and practices survey.Short-term, low-dose GH therapy improves insulin sensitivity without modifying cortisol metabolism and ectopic fat accumulation in adults with GH deficiencyEffects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men.Insulin-like growth factor I and impaired glucose tolerance.Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistanceTherapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults.An examination of the effects of different doses of recombinant human growth hormone on children with growth hormone deficiency.Insulin and IGF-I inhibit GH synthesis and release in vitro and in vivo by separate mechanisms.Effects of 4 weeks recombinant human growth hormone administration on insulin resistance of skeletal muscle in ratsEffects of growth hormone (GH) therapy withdrawal on glucose metabolism in not confirmed GH deficient adolescents at final height.The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations.Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.Oral contraception enhances growth hormone responsiveness to hyper- and hypoglycaemia.Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation.Evaluation of left ventricular mass and function, lipid profile, and insulin resistance in Egyptian children with growth hormone deficiency: A single-center prospective case-control study.Central ghrelin regulates peripheral lipid metabolism in a growth hormone-independent fashion.Effects of growth hormone on glucose metabolism and insulin resistance in human.Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.Glucose homeostasis in abdominal obesity: hepatic hyperresponsiveness to growth hormone action.The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance.Insulin sensitivity in growth hormone-deficient children: influence of replacement treatment.Glucose metabolism and visceral fat in GH deficient adults: two years of GH-replacement.Effects of 2 wk of GH administration on 24-h indirect calorimetry in young, healthy, lean men.Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.Difference between Japanese and Caucasian populations in the allelic frequency of growth hormone receptor polymorphisms.Inhibin βE (INHBE) is a possible insulin resistance-associated hepatokine identified by comprehensive gene expression analysis in human liver biopsy samples.Glucose Metabolism in Children With Growth Hormone Deficiency.
P2860
Q24618226-151EC90E-1708-4A9B-8CED-5DC83FDD76E7Q24645123-056756D9-4297-4F86-9CB7-2464B39D4496Q28508170-A26E0CE8-8744-4EF7-A6FA-ECE86C1BD0DCQ33569163-E890EF8D-8285-43D1-BCAA-B8EB875C6822Q33697158-8E3E48DE-3339-436E-AECD-99D3EF83B968Q33803331-FF5AD16B-0189-45E5-8F9F-465DC678CC16Q34189815-1A0B0D36-89D9-4C34-93B1-3A61BF809BB1Q34284698-006D3632-C04B-4451-9DA9-C819AA621670Q34571826-574EB3CB-01BC-4DF2-9084-B5C936EB8EF2Q36068084-7F389395-F821-4135-818F-0A252F1E0A48Q36322951-55B7814E-715C-4578-8FFD-67E0DBB3640AQ36697737-B5FA4559-A897-436F-B97B-16BDA5448091Q36824977-53FA4785-B3BB-4776-A8CC-72518F2D2C3FQ36946068-078C49C5-9312-4A79-A40D-09267D9121D1Q37065215-E6221E6D-9215-499C-B507-E1F94A7910F6Q37534519-9E32DA09-7749-490F-BC2E-A3585DFE2189Q38097351-A8136BA4-E98F-41A8-B709-5D2CB0B197E1Q38683309-F663C8D9-3D1A-48C5-A2E9-DC6DFACAAA82Q39711846-1BB5D54C-0FC3-43FE-8A69-929B305378F1Q40373514-88DDF920-38CC-4B60-97DD-43DEF03033B5Q41980483-36997153-A106-4EEF-BE5C-28C0CBDA2864Q42153443-72477617-57DA-44EB-B413-E53024E90B5CQ42378179-556BC63B-3EE0-44FE-BBCC-9A0E08689B40Q42668786-50ADB520-0AF6-4E7C-97B4-F3C595EE982EQ44768339-CC4AF84F-07C7-4D99-87A6-24A20C0BF0DAQ44818645-7B74D941-4F85-4D8A-B3BF-FFACA7EA89E9Q45097779-1D2381DF-DF8A-4C68-9958-8F77F64FDCC7Q46836109-E4FA5250-55E2-45AA-A39F-F64D8FB6D27BQ47757053-364E1A16-4253-4C2E-8428-8037F335ED18Q51498823-F7195C5D-29FA-46B7-A2B7-582FDB52D416Q51736999-DD48FB82-4F26-4CB9-AB25-34587547239BQ52622038-AF03F634-B774-453F-8D4D-EDFED4F5C7F0Q55252126-A97DE68B-8A02-4331-A4A8-A6724BBEC672
P2860
Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Growth hormone replacement the ...... the glucose-fatty acid cycle.
@ast
Growth hormone replacement the ...... the glucose-fatty acid cycle.
@en
Growth hormone replacement the ...... the glucose-fatty acid cycle.
@nl
type
label
Growth hormone replacement the ...... the glucose-fatty acid cycle.
@ast
Growth hormone replacement the ...... the glucose-fatty acid cycle.
@en
Growth hormone replacement the ...... the glucose-fatty acid cycle.
@nl
prefLabel
Growth hormone replacement the ...... the glucose-fatty acid cycle.
@ast
Growth hormone replacement the ...... the glucose-fatty acid cycle.
@en
Growth hormone replacement the ...... the glucose-fatty acid cycle.
@nl
P2093
P356
P1476
Growth hormone replacement the ...... the glucose-fatty acid cycle.
@en
P2093
Esa Laurila
Jens R Daugaard
Margareta Bramnert
Mikael Segerlantz
Per Manhem
P304
P356
10.1210/JC.2002-020542
P407
P50
P577
2003-04-01T00:00:00Z